A Case of JAK2V617F-Negative Myeloproliferative Neoplasm in a Young Female Presenting With Extreme Thrombocytosis

被引:0
|
作者
Kumar, Kelash [1 ]
Koubeissy, Assile [1 ]
Pulenthiran, Arichanah [1 ]
Kumar, Amrat [2 ]
Gulati, Amit [1 ]
Wolf, Brian [3 ]
Peeke, Stephen [3 ]
机构
[1] Maimonides Hosp, Dept Internal Med, Brooklyn, NY 11219 USA
[2] Bassett Med Ctr, Dept Internal Med, Cooperstown, NY USA
[3] Maimonides Hosp, Dept Hematol & Oncol, Brooklyn, NY 11219 USA
关键词
hydroxyurea use; splenomegaly; jak inhibitor; extreme thrombocytosis; chronic myeloid leukemia (cml); CHRONIC MYELOID-LEUKEMIA;
D O I
10.7759/cureus.50679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombocytosis is a commonly observed condition in clinical practice and typically results from various pathophysiological factors, such as iron deficiency, blood loss, infection, medications, rheumatologic conditions, malignancy, asplenia, post-splenectomy, or familial factors. However, extreme thrombocytosis, defined as a platelet count > 10,000 K/UL (equal or greater than a million), is a rare occurrence. In this report, we present a compelling case of severe thrombocytosis attributed to underlying chronic myelogenous leukemia (CML), further complicated by coexisting iron deficiency. It is essential to emphasize that not all instances of extreme thrombocytosis are indicative of essential thrombocythemia. Hence, maintaining a high level of suspicion for non-ET myeloproliferative neoplasms (MPNs) such as CML, as well as other underlying conditions like iron deficiency anemia, is crucial for accurate diagnosis and timely management.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm
    Li, Z. C.
    Fu, H. J.
    Wang, Z. M.
    Yang, S.
    Xu, H. Z.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03):
  • [42] Discussion of the correlation between JAK2V617f mutation and thromboembolism in myeloproliferative neoplasm patients
    Xia, L.
    Wu, J-S
    Ding, K-Y
    Zeng, Q-S
    Cai, X-Y
    Zhu, W-B
    Wu, L-L
    Liu, X.
    Yang, H-Z
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 635 - 636
  • [43] Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
    Marty, Caroline
    Lacout, Catherine
    Martin, Antoine
    Hasan, Salma
    Jacquot, Sylvie
    Birling, Marie-Christine
    Vainchenker, William
    Villeval, Jean-Luc
    BLOOD, 2010, 116 (05) : 783 - 787
  • [44] Evaluation of JAK2V617F mutation prevalence in myeloproliferative neoplasm by AS-RT-PCR
    Karimzadeh, P.
    Ghaffari, S. H.
    Chahardouli, B.
    Zaghal, A.
    Einollahi, N.
    Mousavi, S. A.
    Bahar, B.
    Dargahi, H.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    Togheh, G. R.
    Nadali, F.
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 1 (02) : 38 - 42
  • [45] Stat3 Negatively Regulates Myeloproliferative Neoplasm Induced By Jak2V617F
    Yan, Dongqing
    Mohi, Golam
    BLOOD, 2013, 122 (21)
  • [46] The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm
    Sangkhae, Veena
    Etheridge, S. Leah
    Kaushansky, Kenneth
    Hitchcock, Ian S.
    BLOOD, 2014, 124 (26) : 3956 - 3963
  • [47] Crucial Role of Jak2V617f-positive Myeloproliferative Neoplasm in the Development of Aortic Aneurysm
    Yokokawa, Tetsuro
    Misaka, Tomofumi
    Kimishima, Yusuke
    Wada, Kento
    Minakawa, Keiji
    Sugimoto, Koichi
    Ishida, Takafumi
    Ikeda, Kazuhiko
    Takeishi, Yasuchika
    CIRCULATION, 2020, 142
  • [48] PREVALENCE OF JAK2V617F MUTATION AND ITS CLINICAL CORRELATION IN THAIS WITH MYELOPROLIFERATIVE NEOPLASM
    Chanprasert, S.
    Suksomyos, N.
    Maunpasitporn, C.
    Ponlapat, R.
    HAEMATOLOGICA, 2012, 97 : 643 - 643
  • [49] Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation
    Yasuda, Shunichiro
    Chiba, Momoko
    Nishitani, Rie
    Watanabe, Takako
    CLINICAL CASE REPORTS, 2024, 12 (04):
  • [50] Leukemic blasts in transfon-ned JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation
    Theocharides, Alexandre
    Boissinot, Marjorie
    Girodon, Francois
    Garand, Richard
    Teo, Soon-Siong
    Lippert, Eric
    Talmant, Pascaline
    Tichelli, Andre
    Hermouet, Sylvie
    Skoda, Radek C.
    BLOOD, 2007, 110 (01) : 375 - 379